The Latest DRX9000™ Study Data Published In Peer-Reviewed Journal!

A study titled, "Prospective Evaluation of the Efficacy of Spinal Decompression via the DRX9000™ for Chronic Low Back Pain" was published in the December issue of The Journal of Medicine. The study authored by Dr. John Leslie, Mayo Clinic, et al, was designed to evaluate the effectiveness and safety of the DRX9000™ in the treatment of chronic lower back pain. Patients enrolled in the study had suffered an overall average of 266 weeks of low back pain. At the conclusion of the study, 16 of the 18 patients reported improvement in low back pain, greater than 50%. The authors state, "Patients also reported having better daily activity function as measured by the Oswestry Disability Index." Reprints are available through Axiom Worldwide. To view this article please visit here.



About Axiom Worldwide



Axiom Worldwide manufactures and distributes its flagship products, the DRX9000 True Non-surgical Spinal Decompression System™, DRX9000C™, and DRX9500™ in medical markets around the globe. Axiom also manufactures a digital electroceutical device, the EPS8000™, for use in relieving pain and for use in muscular rehabilitation. Axiom prides itself on providing safe, non-surgical alternatives that patients should consider prior to undergoing surgery. For additional information please visit: http://www.AxiomWorldwide.com. To schedule an interview please contact: Amber Pacetti, Marketing at: telephone: 001-813-249-6444 or email: apacetti@axiomworldwide.com.



Axiom Worldwide

• Correcting Elementary Football Practicing Suggestions Posted By : Wellington W
• Rite Aid Updates List Of Products Included In February 6 Voluntary Peanut Product Recall
• Johns Hopkins Researchers Discover How Critical Cancer Gene Controls Nutrient Use